The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.
Adenovirus vaccine vectors generated from new viral serotypes are routinely screened in pre-clinical laboratory animal models to identify the most immunogenic and efficacious candidates for further evaluation in clinical human and veterinary settings. Here, we show that studies in a laboratory speci...
主要な著者: | Dicks, M, Guzman, E, Spencer, A, Gilbert, S, Charleston, B, Hill, A, Cottingham, M |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Elsevier
2015
|
類似資料
-
Uncovering the mechanisms of adenovirus vector immunogenicity
著者:: Dicks, M, 等
出版事項: (2013) -
A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
著者:: Dicks, M, 等
出版事項: (2012) -
Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
著者:: Dicks, M, 等
出版事項: (2015) -
A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
著者:: Matthew D J Dicks, 等
出版事項: (2012-01-01) -
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
著者:: Warimwe, G, 等
出版事項: (2013)